These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22133878)

  • 41. Phospholamban ablation in hearts expressing the high affinity SERCA2b isoform normalizes global Ca²⁺ homeostasis but not Ca²⁺-dependent hypertrophic signaling.
    Louch WE; Vangheluwe P; Bito V; Raeymaekers L; Wuytack F; Sipido KR
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2574-82. PubMed ID: 22505640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin.
    Knollmann BC; Knollmann-Ritschel BE; Weissman NJ; Jones LR; Morad M
    J Physiol; 2000 Jun; 525 Pt 2(Pt 2):483-98. PubMed ID: 10835049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
    Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
    J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRPC channels are necessary mediators of pathologic cardiac hypertrophy.
    Wu X; Eder P; Chang B; Molkentin JD
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caveolae-localized L-type Ca2+ channels do not contribute to function or hypertrophic signalling in the mouse heart.
    Correll RN; Makarewich CA; Zhang H; Zhang C; Sargent MA; York AJ; Berretta RM; Chen X; Houser SR; Molkentin JD
    Cardiovasc Res; 2017 Jun; 113(7):749-759. PubMed ID: 28402392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Ca(2+)-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Calpha.
    Muth JN; Bodi I; Lewis W; Varadi G; Schwartz A
    Circulation; 2001 Jan; 103(1):140-7. PubMed ID: 11136699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal calcium sensor-1 promotes immature heart function and hypertrophy by enhancing Ca2+ signals.
    Nakamura TY; Jeromin A; Mikoshiba K; Wakabayashi S
    Circ Res; 2011 Aug; 109(5):512-23. PubMed ID: 21737792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cdc42 is an antihypertrophic molecular switch in the mouse heart.
    Maillet M; Lynch JM; Sanna B; York AJ; Zheng Y; Molkentin JD
    J Clin Invest; 2009 Oct; 119(10):3079-88. PubMed ID: 19741299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow.
    Andersen ND; Ramachandran KV; Bao MM; Kirby ML; Pitt GS; Hutson MR
    J Mol Cell Cardiol; 2015 Mar; 80():1-9. PubMed ID: 25536179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes.
    Jaleel N; Nakayama H; Chen X; Kubo H; MacDonnell S; Zhang H; Berretta R; Robbins J; Cribbs L; Molkentin JD; Houser SR
    Circ Res; 2008 Nov; 103(10):1109-19. PubMed ID: 18832749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel.
    Song LS; Guia A; Muth JN; Rubio M; Wang SQ; Xiao RP; Josephson IR; Lakatta EG; Schwartz A; Cheng H
    Circ Res; 2002 Feb; 90(2):174-81. PubMed ID: 11834710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
    Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
    Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.
    Wu X; Chang B; Blair NS; Sargent M; York AJ; Robbins J; Shull GE; Molkentin JD
    J Clin Invest; 2009 Apr; 119(4):976-85. PubMed ID: 19287093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CIB1 is a regulator of pathological cardiac hypertrophy.
    Heineke J; Auger-Messier M; Correll RN; Xu J; Benard MJ; Yuan W; Drexler H; Parise LV; Molkentin JD
    Nat Med; 2010 Aug; 16(8):872-9. PubMed ID: 20639889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
    Liu Q; Sargent MA; York AJ; Molkentin JD
    Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.
    Han JW; Lee YH; Yoen SI; Abramowitz J; Birnbaumer L; Lee MG; Kim JY
    Mol Cell Biochem; 2016 Oct; 421(1-2):55-65. PubMed ID: 27522668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice.
    Nakayama H; Bodi I; Correll RN; Chen X; Lorenz J; Houser SR; Robbins J; Schwartz A; Molkentin JD
    J Clin Invest; 2009 Dec; 119(12):3787-96. PubMed ID: 19920353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.